170 related articles for article (PubMed ID: 36355170)
1. Non-Targeted Serum Lipidomics Analysis and Potential Biomarkers of Laryngeal Cancer Based on UHPLC-QTOF-MS.
Wang H; Luo Y; Chen H; Hou H; Hu Q; Ji M
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36355170
[TBL] [Abstract][Full Text] [Related]
2. Lipidomics Identified Lyso-Phosphatidylcholine and Phosphatidylethanolamine as Potential Biomarkers for Diagnosis of Laryngeal Cancer.
Yu B; Wang J
Front Oncol; 2021; 11():646779. PubMed ID: 34262857
[TBL] [Abstract][Full Text] [Related]
3. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
[TBL] [Abstract][Full Text] [Related]
4. [Nontargeted lipidomic analysis of sera from sepsis patients based on ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry].
Wang S; Liang J; Shi H; Xia Y; Li J; Wu W; Wang H; Wu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):346-351. PubMed ID: 35692196
[TBL] [Abstract][Full Text] [Related]
5. Lipidomics based on UHPLC/Q-TOF-MS to characterize lipid metabolic profiling in patients with newly diagnosed type 2 diabetes mellitus with dyslipidemia.
Zhong X; Xiao C; Wang R; Deng Y; Du T; Li W; Zhong Y; Tan Y
Heliyon; 2024 Feb; 10(4):e26326. PubMed ID: 38404868
[TBL] [Abstract][Full Text] [Related]
6. [Lipid metabolism study of sodium norcantharidate in LO2 hepatocytes based on lipidomics].
Zhao LJ; Si N; Gao B; Wei XL; Wang YL; Zhao HY; Bian BL
Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(1):158-166. PubMed ID: 30868827
[TBL] [Abstract][Full Text] [Related]
7. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
9. Combined untargeted and targeted lipidomics approaches reveal potential biomarkers in type 2 diabetes mellitus cynomolgus monkeys.
Tian CY; Yang QH; Lv HZ; Yue F; Zhou FF
J Med Primatol; 2024 Feb; 53(1):e12688. PubMed ID: 38083989
[TBL] [Abstract][Full Text] [Related]
10. Assessment of plasma amino acids, purines, tricarboxylic acid cycle metabolites, and lipids levels in NSCLC patients based on LC-MS/MS quantification.
Cang S; Liu R; Mu K; Tang Q; Cui H; Bi K; Zhang Y; Li Q
J Pharm Biomed Anal; 2022 Nov; 221():114990. PubMed ID: 36208488
[TBL] [Abstract][Full Text] [Related]
11. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.
Shen S; Yang L; Li L; Bai Y; Cai C; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():41-48. PubMed ID: 29028617
[TBL] [Abstract][Full Text] [Related]
12. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolomics of laryngeal cancer based on liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Zhang X; Hou H; Chen H; Liu Y; Wang A; Hu Q
Biomed Chromatogr; 2018 May; 32(5):e4181. PubMed ID: 29272549
[TBL] [Abstract][Full Text] [Related]
14. Serum lipidomics profiles reveal potential lipid markers for prediabetes and type 2 diabetes in patients from multiple communities.
Xuan Q; Hu C; Zhang Y; Wang Q; Zhao X; Liu X; Wang C; Jia W; Xu G
Front Endocrinol (Lausanne); 2022; 13():966823. PubMed ID: 36060983
[TBL] [Abstract][Full Text] [Related]
15. Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics.
Wang S; Tang K; Lu Y; Tian Z; Huang Z; Wang M; Zhao J; Xie J
Clin Chim Acta; 2021 Feb; 513():34-42. PubMed ID: 33307061
[TBL] [Abstract][Full Text] [Related]
16. Serum lipid profiling analysis and potential marker discovery for ovarian cancer based on liquid chromatography-Mass spectrometry.
Wang Y; Wang Y; Chen C; Ren F; Cao R; Wang Y; Han P; Zhang X; Xu C; Liu X; Xu G
J Pharm Biomed Anal; 2021 May; 199():114048. PubMed ID: 33836461
[TBL] [Abstract][Full Text] [Related]
17. UHPLC-MS/MS-based untargeted lipidomics analysis of septic patients.
Liang J; Li J; Zhang J; Rong J; Wang X; Zhao C; Zhang H; Shi H; Wu W
Clin Chim Acta; 2023 Apr; 544():117336. PubMed ID: 37031781
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
19. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
[TBL] [Abstract][Full Text] [Related]
20. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
